[ Price : $8.95]
Federal Register notice: FDA corrects an 8/20 notice to reflect the correct dates that the support and requirement were to begin f...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Circumstances that Constitute Delaying, Denying, Limiting, ...[ Price : $8.95]
FDA issues a draft update to guidance for industry #152, Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Th...[ Price : $8.95]
FDA clears a Providence Medical Technology Cavux Facet Fixation System (FFS) for spinal surgery patients requiring a revision for ...[ Price : $8.95]
Dr. Reddys subsidiary Aurigene Oncology halts the development of its psoriasis investigational drug after reporting poor results o...[ Price : $8.95]
FDA publishes a revised guidance incorporating GDUFA 3 performance goals for complete response letter activities.[ Price : $8.95]
FDA approves revised labeling for Genentechs Xeloda.[ Price : $8.95]
FDA extends by three months its review of an AstraZeneca and Merck supplemental NDA for Lynparza (olaparib) in combination with Ja...